ApoB May Better Predict Mortality Risk in Statin-Treated Patients
A new study shows apolipoprotein B (apoB) and non-high-density-lipoprotein (non-HDL) cholesterol — but not low-density-lipoprotein (LDL) cholesterol — are associated with …
Home »
A new study shows apolipoprotein B (apoB) and non-high-density-lipoprotein (non-HDL) cholesterol — but not low-density-lipoprotein (LDL) cholesterol — are associated with …
The rate of cardiovascular risk factors among Hispanic/Latino people living in the U.S. is very high, and while they are …
(HealthDay)—The majority of young heart attack patients with familial hypercholesterolemia (FH) still have elevated cholesterol levels a year later, according …
A new study shows more aggressive treatment may be needed for a large number of patients taking statin medications, and …
Clinical trials have shown that cholesterol-lowering statin drugs can significantly reduce the risk of cardiovascular disease in kidney disease patients …